I agree, in the absence of any post-marketing safety issues, it makes sense that this will be the delivery approach for these drugs in the future.
As I was saying before, the economic opportunity will be linked to the granting and defensibility of patents. Otherwise will be a very competitive, low margin business.
Revenue - what does it look like?, page-73
Add LTP (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.71 |
Change
0.015(0.89%) |
Mkt cap ! $144.5M | |||
| Open | High | Low | Value | Volume |
| $1.70 | $1.79 | $1.69 | $490.7K | 282.7K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 10566 | $1.71 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.75 | 1600 | 1 |
View Market Depth
| Last trade - 16.10pm 02/10/2024 (20 minute delay) ? |
| LTP (ASX) Chart |